The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin
- 1 February 1979
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 11 (2) , 133-146
- https://doi.org/10.1016/s0031-6989(79)80067-3
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Platelet aggregation and thromboxane A2 formation in cat platelet rich plasmaPharmacological Research Communications, 1978
- Aspirin inhibits platelet aggregation on, but not adhesion to, collagen fibrils: An assessment of platelet adhesion and deposited platelet mass by morphometry and 51Cr-labelingThrombosis Research, 1977
- Selective inhibition of thromboxane A2 biosynthesis in blood plateletsNature, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood plateletsPharmacological Research Communications, 1977
- Prostaglandin and thromboxane biosynthesis inhibitorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1977
- Biosynthesis of thromboxane B2: Assay, isolation, and properties of the enzyme system in human plateletsProstaglandins, 1976
- A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregationProstaglandins, 1976
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976
- Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2Nature New Biology, 1973